Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Gross Profit: 2017-2024

Historic Gross Profit for Puma Biotechnology (PBYI) over the last 8 years, with Dec 2024 value amounting to $166.1 million.

  • Puma Biotechnology's Gross Profit fell 17.77% to $42.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.0 million, marking a year-over-year decrease of 3.39%. This contributed to the annual value of $166.1 million for FY2024, which is 3.98% down from last year.
  • As of FY2024, Puma Biotechnology's Gross Profit stood at $166.1 million, which was down 3.98% from $173.0 million recorded in FY2023.
  • In the past 5 years, Puma Biotechnology's Gross Profit ranged from a high of $194.9 million in FY2022 and a low of $166.1 million during FY2024.
  • Over the past 3 years, Puma Biotechnology's median Gross Profit value was $173.0 million (recorded in 2023), while the average stood at $178.0 million.
  • Per our database at Business Quant, Puma Biotechnology's Gross Profit dropped by 21.11% in 2020 and then grew by 2.88% in 2022.
  • Over the past 5 years, Puma Biotechnology's Gross Profit (Yearly) stood at $185.7 million in 2020, then grew by 2.00% to $189.5 million in 2021, then increased by 2.88% to $194.9 million in 2022, then decreased by 11.26% to $173.0 million in 2023, then dropped by 3.98% to $166.1 million in 2024.